Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice history

Adamas Pharmaceuticals, Inc. News

5 Top Stock Gainers for Monday: Aspen, SoFi, Flexion Therapeutics

Aspen Technology, Sofi Technologies, Flexion Therapeutics, Adamas Pharmaceuticals and Ocular Therapeutix are five top stock gainers for Monday.

MediWound Shares Lower After Pricing Stock Offering - Biotech Movers

MediWound priced an underwritten public offering of 4.4 million shares at $5 apiece.

Adamas Skyrockets on FDA Approval for Dyskinesia Treatment - Biotech Movers

The Emeryville, Calif.-based firm secures FDA approval for Gocovri as a treatment for dyskinesia in Parkinson's disease patients.

Hurricane Harvey, Now a Category 2, Heads for Oil-Rich Gulf Coast

Hurricane Harvey was upgraded to a category 2 storm overnight and could be a category 3 before the day is over.

Biotech's are quite active Tuesday. Find Out who's moving and why:

Biogen's new spine disease drug outperformed expectations during its commercial debut.

Breaking News

The Good Times Are Over for Startups

Sequoia Capital and Y Combinator have told startups that cutting costs is a priority.

Elon Musk Throws Dogecoin a Lifeline

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

Disney Fans Angry, Excited About New Guardians of the Galaxy Ride

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora Cannabis Slashing Weed Capacity in Profitability Push

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.